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(57) ABSTRACT 
A cell growth matrix for optimizing 3D organization nutrient 
delivery, controlling release of differentiation factors and 
facilitating attachment of cells to a scaffold Colloidal crystals 
and inverted colloidal crystals are used to form an ordered 
structure for use as a scaffold for tissue engineering. The 
porosity of the cell growth matrix may be modified by the 
selection of particles of appropriate diameter. Further, the 
surface of colloidal crystals can be easily modified to accom-
modate many organic species including biomolecules. Layer-
by-layer materials are used for tissue engineering to control 
cell development by using sequential layering of bioactive 
species wherein the number and order of LBL layers depos-
ited between layers containing a particular protein are con-
trolled. LBL may also be used for timed release ofbioactive 
species. Increased control differentiation factors release and 
control of cell attachments to the scaffold are achieved to 
better mimic natural tissue development. 
29 Claims, 9 Drawing Sheets 
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FIG. 1. Layer-by-layer assembly schematics. 
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FIG. 2. Model LBL film 
structure: I - polyelectrolyte, 2-
proteins, 3 - particles or 
different proteins. 
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FIG. 3. SEM micrograph ofa colloidal crystal made by 
electrophotetic deposition oflatex polymer particles. 
The diameter of the particles is 600 nm. 
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FIG. 4. AFM image ofPDDA/PANcollagen assembly. 
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FIG. 5. Attachment ofC2Cl2 (a) and 
PCl2 (b) cells to collagen LBL 
multi layers. 
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Figure 6A. SEM image of laser-treated scaffold with focused light. 
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Figure 6B. SEM image of laser-treated scaffold with defocused light. 
The top left corner represents the untreated surface. The bottom left 
corner shows opening of the pores after illumination. 
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Figure 7 A Confocal fluorescence images of stromal cells on the inverse opal scaffold, 
Top images: bared scaffold; Bottom images: scaffold coated with collagen adhesion 
layer. From Left to right: day 12 and day 21 after cell seeding, respectively. Cells are 
stained with 1 µM CFDA SE (carboxyfluorexein diacetate, succinimidyl ester) a few 
hours prior to imaging. 
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Figure 7B SEM images of human stromal cells (HS-5) cultured on the inverse opal 
scaffold. The cells were fixed, and the scaffold was freeze-cut to expose the inside. The 
zoomed images are on the freeze-cut surface section of the scaffold; therefore, represent 
the distribution of cells inside the scaffold. Size of images (Width x High) from left to 
right: 3.5x2.9 mm,300x250 µm, 75x62 µm. 
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3D TISSUE CONSTRUCTS ON THE BASIS OF 
COLLOIDAL CRYSTALS SURFACE 
MODIFIED BY SEQUENTIAL LAYERING 
CROSS REFERENCE TO RELATED 
APPLICATION 
This application claims the benefit of prior filed copending 
U.S. Provisional Application Ser. No. 60/388,376, filed Jun. 
2 
folds. As well, a versatile surface modification procedure can 
optimization of nutrient delivery and to control the release of 
differentiation factors and attachment of cells to the scaffold. 
"Layer-by-layer" (LBL) is a term used to describe a film 
5 deposition process that has been applied for oppositely 
charged polyelectrolytes. The LBL film deposition process 
has also been extended to the layer-by-layer assembly of 
nanoparticle colloids. LBL procedure involves sequentially 
12, 2002, which application is incorporated herein by refer- 10 
dipping a substrate into solutions of oppositely charged spe-
cies alternating with water rinse. In each dipping cycle, a 
layer of the species, preferably a monolayer or a nano layer, ence. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH 
The Govermnent of the United States of America has cer-
tain rights in this invention pursuant to Grant No. 
BES-0119483 awarded by the National Science Foundation 
and DARPA Grant No. DAMDl 7-02-0702. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates generally to biological archi-
tectural tools, and, more specifically, to the engineering of 
three-dimensional (3D) tissue constructs on the basis of col-
loidal crystals (including inverted ones) and layer-by-layer 
assembly to produce a scaffold for cell growth. 
2. Background 
adsorbs to the substrate. The rinse step removes excess spe-
cies material. Subsequent dipping cycles result in enhanced 
adsorption of an oppositely charged species, which is also 
15 accompanied by a switch in surface charge. The surface 
charge switch promotes the adsorption of a following layer. 
This cycle can be repeated as many times as needed to build 
up a multilayer of desirable thickness. 
One of the major driving forces ofLBL is the electrostatic 
20 attraction between positive and negative charges located on a 
solid surface and polyelectrolytes, colloids and other species 
in solution. Important thermodynamic contributions to film 
stability are also made by van der Waals interactions. Alter-
nation oflayers of positively and negatively charged compo-
25 nents is a key principle of the layer-by-layer assembly. The 
monomolecular nature oflayers deposited in each cycle of the 
LBL technique affords nm scale precision in thin film thick-
ness. 
3D organization of cells largely determines their function 30 
and development. Typical scaffolds for tissue cultures such as 
lactic acid derivatives, poly(lactide-co-glycolide ), fluid 
microspheres, tantalum-coated carbon matrix, metallic 
plates, tricalcium phosphonate, hyaluronan sponges, 
hydroxyapatite, polyester non-woven fabric and others, can 35 
provide some degree of spatial organization of the cells. How-
ever, their micrometer scale architecture structure is not regu-
lar. In order to study the effects of 3D cell contacts one needs 
Since the LBL method is quite simple and effective, it has 
been applied to a variety of charged species from classical 
inorganic colloids to DNAs. Importantly, assembled biopoly-
mers retain their 3D structure and biological activity. This 
property of assembled biopolymers has been utilized for 
enhancement of biocompatibility and attachment of living 
cells to nanostructured composites. 
Overall, there is a recognized need in the field of tissue 
engineering for well ordered 3D tissue constructs with tun-
able surface properties. It is thus an object of the present 
invention to provide methods for engineering improved scaf-
folds for cell growth. 
a scaffold with distinct order. Well-organized structure of the 
scaffolds can help to more accurately determine and realize in 40 
practice the optimal number and modality of intercell con-
tacts, which is critical for adequate tissue development. Addi-
tionally, the uniformity of nutrient fluxes present in ordered 
systems will be beneficial for achieving homogeneity of cells 
developing on the scaffolds including stem cell differentia- 45 
SUMMARY OF THE INVENTION 
According to the present invention, there is provided a cell 
growth matrix that may be used for mimicking natural tissue 
development pressures by providing required 3D organiza-
tion, optimizing nutrient delivery, controlling release of dif-
ferentiation factors and facilitating attachment of cells to a 
tion. 
Therefore, it is important to find a method of preparation of 
cell scaffolds providing 3D crystallinity in the micrometer to 
millimeter scale as well as space sufficient to accommodate 
cells, which be achieved in direct and inverted colloidal crys-
tals. Essentially, colloidal crystals are hexagonally ordered 
lattices of spherical particles with a diameter from several nm 
50 scaffold. This invention describes a new type of 3D cell 
growth matrix which can also increase control over its surface 
properties and other functions such as release of differentia-
tion factors and control of attachment of cells to the scaffold 
to better mimic natural tissue development. 
to several millimeters. As is well known in the art, the colloi-
dal crystals can be easily self-assembled by sedimentation 
and then annealed to form solids. Sedimentation of colloidal 55 One aspect of the invention is the use of colloidal crystals 
particles has traditionally been conducted very slowly to 
organize colloidal crystals into a 3D structure. Other prob-
lems known for currently used scaffolds include pH changes 
during biodegradation which can negatively affect the cell 
development, biocompatibility with some cell cultures, insuf-
ficient cell adhesion and others related to the composition and 
structure of the scaffold surface. These problems may be 
substantially alleviated or eliminated by taking advantage of 
the new surface modification procedure known as layer-by-
layer assembly. Due to universality of this technique it can 
also be applied to achieve desirable surface set of properties 
and activities for different cell cultures and on different scaf-
and inverted colloidal crystals as a scaffold for tissue engi-
neering. The porosity of the cell growth matrix may be modi-
fied by the selection of particles of appropriate diameter. 
Further, the surface of colloidal crystals can be easily modi-
60 fled to accommodate many organic species including biomol-
ecules. 
Another aspect of the invention is the use oflayer-by-layer 
materials for tissue engineering to control cell development 
by using sequential layering ofbioactive species wherein the 
65 number and order of LBL layers deposited between layers 
containing a particular protein are controlled. LBL may also 
be used for timed release ofbioactive species. 
US 7,534,610 Bl 
3 4 
A better understanding of the present invention, its several 
aspects, and its advantages will become apparent to those 
skilled in the art from the following detailed description, 
taken in conjunction with the attached drawings, wherein 
there is shown and described the preferred embodiment of the 5 
invention, simply by way of illustration of the best mode 
contemplated for carrying out the invention. 
switch in surface charge. The switch in surface charge pro-
motes adsorption of the following layer. Preferably, a rinse 
step, e.g., rinse step 18, follows dipping step 16. This cycle 
can be repeated as many times as needed to build up a mul-
tilayer film with a structure of desired thickness as depicted in 
FIG. 2. A more detailed description of the layer-by-layer 
procedure is set out in detail in PCT Publication WO 
00/44507, which publication is incorporated herein by refer-
ence. BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a SEM micrograph of a colloidal crystal made by 
electrophotetic deposition. 
FIG. 2 is a schematic showing a layer-by-layer assembly. 
FIG. 3 is an enlarged view of a model LBL film structure. 
FIG. 4 is anAFM image of a PD DA/PAA/collagen assem-
bly. 
FIG. SA is anAFM image of attachment ofC2C12 cells to 
collagen LBL multilayers. 
FIG. SB is anAFM image of attachment of PC12 cells to 
collagen LBL multilayers. 
FIG. 6A is a SEM image of a laser-treated inverse opal 
scaffold with focused light. 
FIG. 6B is a SEM image of a laser treated inverse opal 
scaffold with defocused light. 
FIG. 7A is confocal fluorescence images of stromal cells 
on the inverse opal scaffold. 
FIG. 7B are SEM images ofhuman stromal cell cultured on 
the inverse opal scaffold. 
FIG. 8 is a fluorescence image of stromal cells on a colloi-
dal crystal scaffold (green luminescence). 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENT 
A new type of cell growth matrix is provided to address 
problems associated with mimicking natural tissue develop-
ment. The proposed 3D cell scaffold may be made by the 
combination of two methods, e.g., layer-by-layer assembly 
(LBL) and colloidal crystals. While colloidal crystal scaf-
folds can be used for cell growth even without subsequent 
surface modification, LBL affords preparation of organized 
layered systems with programmed properties. 
I. Proposed 3D Cell Scaffold. 
In the preferred embodiment, the 3D cell scaffold is made 
by first forming colloidal crystals, as is known in the art, e.g., 
colloidal crystal 10 (see FIG. 1 which is an SEM micrograph 
of colloidal crystal made by electrophotetic deposition of 
latex polymer particles from a suitable material, such as silica 
or latex). The colloidal crystals are then surface modified by 
using the LBL approach. The colloidal crystals may also be 
converted to their inverse replicas producing the so-called 
inverse colloidal crystals in which the voids are located in 
place of the spheres. They are typically produced by infiltrat-
ing the initially formed crystalline assemblies of the spheres 
with a curable solution or a sol-gel composition followed by 
the dissolution or burning of the colloidal spheres. Optionally, 
laser ablation can be used to further modify the structure of 
the as formed composition for optimum cell growth and trans-
portation. 
Generally, the LBL method involves alternation of layers 
of positively and negatively charged components. Referring 
now to FIG. 2, in each dipping cycle, e.g., step 12, a layer, 
preferably a mono layer or nanolayer, of the species adsorb to 
substrate 13, while rinse step 14 removes any excess. The next 
dipping, e.g., step 16, results in enhanced adsorption of an 
oppositely charged species, which is also accompanied by a 
10 For preparation of the 3D cell scaffold, layers of cell adhe-
sion promoters, differentiation factors, growth factors, and 
matrix decomposition factors are built up on a solid 
microporous colloidal crystal by sequentially infiltrating 
them with appropriate polyelectrolytes, proteins and other 
15 species. The microporous support is sequentially immersed 
into solutions of species A and B with corresponding rinsing 
steps in between. This sequence of operations constitutes one 
deposition cycle and results in the production of a film that 
can be generically denoted (A/B). Repetition of the adsorp-
20 tion and rinsing steps for n times results in the formation of a 
coating with a generic structure (A/B)n. The repetition of the 
procedure for a combination of other species, for instance C 
and D, form deposition cycles results in the formation of the 
coating of (AIB)n(CID)m on the microporous scaffold. The 
25 species A, B, C, and D species are exemplified by collagen, 
poly(acrylic acid), cytokines, and polylactic acid respec-
tively. The deposition procedure is expected to work in a wide 
range of concentrations of the mentioned species in aqueous 
and other solutions at ambient conditions. The adsorption 
30 steps typically last for 0.5-60 min, while the period of rinsing 
steps normally do not exceed 1 min. 
One advantage of this approach is that it results in a highly 
ordered 3D structure of photonic crystal and its unique optical 
properties, which can be used to monitor cell attachment and 
35 growth. Cell attachment and growth may be monitored by 
observing the change in scattered, transmitted, or otherwise 
transformed electromagnetic radiation incident on the photo-
nic crystal during cell development. 
Particles of the colloidal crystal solids can be cross-linked 
40 together by means ofbifunctional chemical agents, polymer-
izing compounds, ultrasonication, baking, electromagnetic 
radiation, and other chemical and physical processes. The 
spheres can also be connected to each other by adsorption of 
biodegradable polyelectrolytes such as poly(diallyldimethy-
45 !ammonium chloride (PDDA), poly(ethyleneimine) (PEI), 
poly(allylamine hydrochloride) (PAH), poly(lysine) (PL), 
poly(acrylic acid) (PAA), poly(lactic acid) (PLA) and/or any 
others species that can be processed by LBL. 
In an alternate embodiment, LBL films can be made from 
50 suitable micron-sized particles and weak polyelectrolytes. 
Both polycations and polyanions are used in the assembly 
interlacing the strata, which is made of colloidal particles, e.g. 
5-10000 nm. Afterwards, the assembly is exposed to fairly 
acidic or basic solution, which induces formation of pores and 
55 channels as described by Mendelson and Rubner, incorpo-
rated herein by reference. [Mendelsohn, J. D.; Barrett, C. J.; 
Chan, V. V.; Pal, A. J.; Mayes, A. M.; Rubner, M. F. Fabrica-
tion ofMicroporous Thin Films from Polyelectrolyte Multi-
layers. Langmuir (2000), 16(11), 5017-5023.] 
60 The general composition of LBL films includes a bilayer 
made from weak polycations, such as PAH, PEI, PL, and 
weak polyanions, such as PAA, PLA. A multilayer from these 
polyelectrolytes is assembled in strata connecting portions 
that contain predominantly colloidal particles. After assem-
65 bly, the film on the substrate is immersed in a fairly low pH 
solution, e.g., pH 1-4, to induce phase transition in the mul-
tilayer made from the weak polyelectrolytes. This process 
US 7,534,610 Bl 
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results in formation of pores in the multilayers. The size of the 
pores depends both on the size of the particles and the assem-
bly conditions. Both of these parameters may be adjusted to 
obtain microporous substrates suitable for the cell growth. 
The pore size can be adjusted by changing the diameter of the 5 
incorporated particles and by the pH/ionic strength condi-
tions during the assembly and pore formation. Subsequently, 
the same macroporous system can be sequentially infiltrated 
with biologically active species similar to the method wherein 
colloidal crystals are surface modified, as described above for 10 
colloidal crystal substrates. 
6 
come in contact with adhesion promoters, then with growth 
factors, and then with differentiation agents. 
The use ofLBL-made materials can be used for control of 
cell development by using sequential layering of bioactive 
species. For example, time of "delivery" of a particular pro-
tein to cells can be easily controlled by the number of LBL 
layers deposited between the protein containing layer and the 
cells. The delivery of the desirable protein can be accom-
plished either via its slow diffusion or through the top coating 
or via the decomposition of the latter. The density of the 
coating and its chemical nature affects when a particular 
protein will come in contact with the cell. Controlling time of 
delivery allows programming of cell development by provid-
ing the deposited films in a particular order. It is desirable for 
This approach is suitable for preparing cell scaffolds that 
can be slowly absorbed by the body, if original micron-scale 
particles are made from biodegradable polymers such as poly 
(lactic acid). 
The particles for colloidal crystals and LBL assembly can 
be first made from silica by controlled hydrolysis of tetraethy-
lorthosilicate in water/alcohol mixtures. Dispersions of silica 
15 the entire microporous matrix to be coated conformally and 
uniformly regardless of the geometry of crevices, charmels 
and voids. A uniform coating will create fairly similar condi-
tions and timing of different stages for virtually all cells 
attached to the scaffold. Since LBL is a technique based on 
adsorption, the LBL assembly procedure can create such a 
uniform, conformal coating. 
Following preparation of the cell scaffolds, the cell scaf-
folds are coated with LBL films from materials such as col-
la gen and cell growth factors. LBL films of collagen are easily 
or other colloids are allowed to sediment with or without an 
external electrical field to form a colloidal crystal. The 20 
obtained solids may be calcined at 100-1000° C. to achieve a 
desired structural rigidity. The size and the size distribution of 
the particles can be controlled with the precision within a few 
percent by adjusting the nature and concentration of silicating 
agents, pH, and ionic strength during this procedure. 25 made on a variety of materials. The LBL films, e.g., a PDDA/ 
PAA/collagen assembly 40 (FIG. 4) have a highly porous 
mesh-like structure, which promotes attachment and growth 
of a variety of cells. 
Inverse opal structures are formed from the colloidal crys-
tal by using a curable solution to infiltrate the pores of the 
colloidal crystal. After curing the solution (which may be 
polymetric or may be titania or silica sol-gel), the original 
colloids are destroyed. If the original colloids are latex ( or 30 
other polymers) and the inverse opal is made of titania or 
silica sol-gel, the destruction can be accomplished by heating 
to bum out the latex (or other polymer), leaving only the 
inverse opal oftitania or silica. Other organic colloids can be 
leached out from the infiltrated opals by using a correct sol- 35 
vent. If the original colloids are silica, they can be destroyed 
chemically, for example by hydrofluoric acid. 
Preparation of a microporous substrate by the LBL of 
micron-sized nanoparticles can be made with the same silica 
or other colloids. The production of a cell growth substrate 40 
can be realized by layering not only silica particles but also 
biodegradable polymer colloidal particles made, for instance, 
partially or completely from lactic acid copolymers, natural 
cross-linked proteins, sugars and other compounds and spe-
cies capable of slow decomposition due to chemical or physi- 45 
cal factors. This will allow not only growth of the cells on the 
substrates, but also allows the substrates to be implanted in 
place ofrequired organs. 
Examples of cells include C2C12, designated generally 50 
as shown in FIG. SA and PC12, designated generally 52 as 
shown in FIG. 5B. Cells 50 and 52 are shown attached to 
collagen LBL layers. 
III. Use. 
In addition to the slow digestion of the LBL films, LBL 
may also be used for timed release of bioactive species. 
Examples ofbioactive species include but are not limited to: 
liposomes, capsules, zeolites and others. Timed release of 
bioactive species can also be accomplished by external sig-
nals, such as force field, light, mechanical stress and others. 
Culturing of stem and other cells can be done by techniques 
appropriate to each cell variety, which may need to be opti-
mized for efficient growth in 3D cell scaffolds. The size of the 
particles incorporated in the described 3D scaffolds can be 
used to control porosity of the scaffold and therefore control 
the rate of delivery of nutrients and removal of products of 
cell metabolism. Since the colloidal particles can be synthe-
sized in a wide variety of diameters from 1 nm to 1 micron and 
above, the porosity of the scaffold can also be controlled in 
the same range. 
Colloidal crystals can be shaped into desirable objects both 
prior and subsequent to the biological processing. The actual 
choice will likely depend on the specifics of organ and tissue 
requirements. Colloidal crystal tissue constructs can be 
Laser ablation can be used to further modify the scaffold 
and substrate made using above methods. Vascular like chan- 50 
nels can be made by using focused lasers in controllable sizes 
and distributions on the scaffolds, and lower intensity lasers 
(unfocused beam) can be used to enlarge the connections 
between pores in the inverse opal, to optimize the cell seed-
ing/harvest and nutrient transportation. 55 shaped by allowing sediment in a container of desired geom-
etry. Rigid materials as well as "soft" 3D scaffolds can be 
made from colloidal crystals cross-linked by chemical means 
(polyelectrolytes) by machining the calcined solid. Laser 
ablation of the scaffolds can be used as a type of machining. 
II. Cell Scaffolding with LBL Films. 
Once a skeleton of cell scaffolds is obtained, an LBL film 
formed of cell growth factors, differentiation factors, and cell 
adhesion promoters can be accomplished. The LBL film is 
created by a sequential dipping/rinsing process as discussed 
above and shown in FIG. 2. The sequence of dipping cycles 
determines the sequence of deposited layers. The connecting 
polyelectrolytes act in many ways as molecular glue for the 
biologically active species that control development of the 65 
cells. The connecting polyelectrolytes can be made biode-
gradable. The stem or other cells that coat the matrix will first 
60 It may be necessary to incorporate absorptive agents ( such as 
dyes or nanoparticles) into the scaffold to absorb the laser 
light. 
In some instances, organ shaping can be done by simple 
bending of the substrate. As an example, a cell adhesion 
promoter may be LBL deposited on a thin fiber from glass, 
carbon, biodegradable polymer or other material to facilitate 
the adhesion and differentiation of neural cells. After that, the 
US 7,534,610 Bl 
7 
material having LBL deposited thereon is immersed in a cell 
culture of neural tissue. The cells adhere along the fiber also 
extending processes along it. The shaping of the construct to 
use as a prosthetic device for neural tissue can be as simple as 
bending the flexible fiber into a desirable shape. 
The described 3D cell scaffold may be used for tissue 
replacement in live organisms. Additionally, they may be 
used in a bioreactor for production ofbioactive species such 
8 
times. After heating at 110° C. for 1 h, the matrix was calci-
nated in air at 600° C. for 30 min. The 3D scaffolds were 
obtained. 
EXAMPLE3 
as vaccines. In this case, the rigid 3D scaffolds based on 
photonic crystals and microporous LBL materials may be 10 
particularly advantageous. 
The scaffold geometry was modified and vascular structure 
was introduced into the scaffold for improved cell seeding/ 
harvest and nutrient delivery by laser ablation of the scaffold. 
Inverse opal scaffolds were subjected to 308 nm excimer laser 
radiation for 10 pulses over the area of 1.55 cm2 . Efficient 
removal of the matrix was observed. This treatment can be 
used to modify the scaffolds to improve the nutrient delivery 
to the cells. FIG. 6A shows an SEM image of a vascular like 
The grown cells can be harvested from the scaffolds. Har-
vesting of cells may be accomplished by introduction of 
special layers in the LBL film structure made from polymers, 
colloids, proteins and other species, that can lose their struc-
tural integrity under chemical exposure, action of bioactive 
species and/or external force fields, light, mechanical stress, 
etc. 
15 structure introduced by focused laser beam on the scaffold. 
The experiment demonstrated the ability to introduce size 
controllable channels into the scaffold for optimal transpor-
tation into the scaffold. 
The method and resulting constructs of the present inven-
tion have many advantages. Among other advantages, this 20 
proposed approach to cell scaffolding provides exceptional 
advantages for tissue engineering including: 
FIG. 6B shows an SEM image of laser-treated scaffold 
with defocused light. The top left comer represents the 
untreated surface. The bottom left corner shows opening of 
the pores after illumination. This experiment demonstrated an 
optical way to modify the pore and connection channel size. 
(1) the porosity of the material can be very well controlled 




(2) the material can be molded into any desirable shape; 
(3) surface modification of the colloidal particles (photonic 
crystal) or pores (LBL microporous composite) pro-
vides optimum adhesion of stem cells; 
( 4) special biological factors can be incorporated in a struc-
ture of the multilayers in a desired order so that the cells 
receive time-programmed signals. For example, one can 
incorporate a layer of cytokines underneath the layer of 
adhesion promoter such as collagen; and 
The layer-by-layer films were deposited after the inverse 
opal samples had been cured. The deposition sequence was 
10 minutes in a 0.5% polydiallyldimethylammonium chlo-
30 ride (PDDA) aqueous solution (pH set to 3 with HCI/NaOH), 
rinse with water, 10 minutes in a 0.5% poly(acrylic acid) 
(PAA) aqueous solution (M.W.=450,000, pH set to 4), rinse, 
20 minutes in a 0.1 % aqueous solution of collagen III (pH set 
to 4), rinse, 10 minutes in the PAA solution, rinse, 20 minutes 
35 in the collagen III solution, and rinse. 
(5) special structural layers can be put in the foundation of 
the LBL multilayer structure that can disrupt the con-
nectivity of the multilayers by the action of the external 
fields or other stimuli. Thus, the entire assembly may be 
delaminated and the attached cells released. For 40 
EXAMPLE 5 
Growth of Strama! Cells on the Coated Inverse Opal 
Scaffold 
instance, a polyelectrolyte undergoing a photoinduced 
decomposition can be deposited prior to cell adhesion 
promoters. Then, the illumination with light will cause 
the breakdown of the connectivity in the polyelectrolyte 
multilayers, and therefore, the delamination of the top 45 
layers. 
Human stromal cell (HS-5, ATCC Catalog# CRL-11882) 
was seeded on the inverse opal scaffold, placed in a 24 well 
cell culture plate and incubated at 37° C. and 5% CO2 level. 
ATCC recommended culture medium was used: Dulbecco's 
modified Eagle's Medium with: 4 mM L-glutamine, 4.5 g/L 
glucose, 1.5 g/L sodium bicarbonate (ATTC 30-2002), 
supplemented with: 10% fetal bovine serum (ATCC 
30-2021), and 1% penicillin-streptomycin (Sigma P3539). 
The present invention will be further understood with ref-
erence to the following non-limiting experimental examples. 
EXAMPLE 1 
A colloidal crystal is formed. A centrifugation tube was cut 
and was stuck on a glass plate. The equal volume mixture of 
the aqueous solution of 75 µm 0.27% polystyrene beads and 
1:1 H2O/DMF solution was dropped in the tube. Then the 
tube was placed in a beaker, which was covered with alumi-
num foil with small holes and then heated at 60° C. The 
solution was evaporated slowly and colloidal crystals were 
obtained after 2-3 days. 
EXAMPLE2 
Na2SiO3 solution was diluted with equal volume deion-
ized water and then was infiltrated into the resulting colloidal 
crystals, which were dried in air naturally to let Na2SiO3 sol 
become gel. The infiltrating procedure could be repeated two 
50 Medium were changed every 2-4 days according to the cell 
growth rate. 
The cell adhesion and proliferation was visualized via con-
focal fluorescence microscopy and scanning electron micros-
copy (SEM). FIG. 7A shows the confocal images of stromal 
55 cell growth on the scaffold with and without LBL coated 
collagen adhesion layer. Cells are stained with low concen-
tration (1 µM) CFDA SE (carboxyfluorexein diacetate, suc-
cinimidyl ester) a few hours prior imaging to reduce disturb of 
normal cell growth. The excitation wavelength is 488 nm, and 
60 emission is collected between 515 and 550 nm. Strama! cells 
were observed to adhere, proliferate and grow exceptionally 
well on the prepared 3D scaffolds. The cell growth rate is 
clearly higher on the collagen coated scaffold. 
FIG. 7B shows the SEM image of stromal cells inside the 
65 scaffold. The cells were fixed, and the scaffold was freeze-cut 
to expose the inside. The zoomed images are on the freeze-cut 
surface section of the scaffold; therefore, they represent the 
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distribution of cells inside the scaffold. The true 3D organi-
zation of stromal cells has been obtained. The organization of 
the cells resembles that of the bone marrow tissue. 
FIG. 8 shows a fluorescence image of stromal cells on a 
colloidal crystal scaffold (green luminescence). 5 
It will be apparent to those skilled in the art that the process 
herein described for producing a scaffold for cell growth and 
tissue engineering can be adapted in a multitude of ways. 
While the invention has been described with a certain 
degree of particularity, it is manifest that many changes may 10 
be made in the details of the process of assembly without 
departing from the spirit and scope of this disclosure. It is 
understood that the invention is not limited to the experimen-
tal methods set forth herein for purposes of exemplification. 
We claim: 15 
1. A method of facilitating cell growth and tissue engineer-
ing with a scaffold comprising: 
immersing a porous colloidal crystal structure into a solu-
tion or dispersion comprising PDDA under conditions 
such that the PDDA coats 20 
said porous colloidal crystal structure with a thin film com-
prised of PDDA to form the scaffold, said PDDA having 
an affinity for said porous colloidial crystal structure; 
seeding cells on said scaffold; 
culturing said scaffold, where said cells are allowed to 25 
perform their biological functions. 
2. The method according to claim 1 further comprising: 
at least one of rinsing and drying said porous colloidal 
crystal structure. 
3. The method according to claim 1 wherein: 30 
said step of coating further comprises additional steps of 
rinsing said porous colloidal crystal structure with a 
solvent. 
4. The method according to claim 1 wherein: 
said step of coating further includes drying the porous 35 
colloidal crystal structure after rinsing. 
5. The method according to claim 1 further comprising: 
monitoring cell attachment and growth by observing a 
change in phenomena selected from the group consist-
ing of scattered, transmitted, and otherwise transformed 40 
electromagnetic radiation incident on the colloidal crys-
tal. 
6. The method according to claim 1 wherein: 
said colloidal crystal is sedimented in a mold to achieve a 
desired shape. 45 
7. The method according to claim 1 wherein: 
laser ablation is used to obtain a desired shape of the 
scaffold. 
8. The method according to claim 1 wherein: 
mechanical manipulation is used to obtain a desired shape 50 
of the scaffold. 
9. The method according to claim 1 wherein said biological 
functions of said cells are selected from a group consisting of 
adhesion, growth, proliferation, differentiation, migration, 
apoptosis, self organization into tissue, and combinations 55 
thereof. 
10. The method according to claim 1 wherein: 
said porous colloidal crystal structure is an inverse opal or 
inverted colloidal crystal. 
11. The method according to claim 10 further comprising: 60 
monitoring cell attachment and growth by observing the 
change in phenomena selected from a group consisting 
of scattered, transmitted, or otherwise transformed elec-
tromagnetic radiation incident on said inverse opal. 
12. The method according to claim 10 wherein: 65 
said inverse opal is sedimented in a mold to achieve a 
desired shape. 
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13. The method according to claim 10 wherein: 
said inverse opal is machined to achieve the desired shape. 
14. The method according to claim 10 wherein: 
laser ablation is used to obtain a desired shape of the 
scaffold. 
15. The method according to claim 10 wherein: 
mechanical manipulation is used to obtain a desired shape 
of the scaffold. 
16. The method according to claim 10 further comprising: 
including layers in the coating that lose their structural 
integrity when exposed to treatments selected from a 
group consisting of chemicals, bioactive species, 
mechanical forces, electric fields, magnetic fields, and 
electromagnetic radiation. 
17. The method according to claim 1 further comprising a 
step of immersing said porous colloidal crystal structure in a 
second solution or dispersion of a second substance, said 
second substance having an affinity for said first substance. 
18. The method according to claim 17 wherein: 
said dispersion or solution of second substance is a solution 
or dispersion comprising bioactive species selected 
from a group consisting of cell adhesion promoters, 
differentiation factors, and growth factors. 
19. The method according to claim 18 wherein: 
said cell adhesion promoters comprise collagen or extra-
cellular matrix, or combinations thereof. 
20. The method according to claim 18 wherein: 
said differentiation factors are selected from a group con-
sisting of cytokines, chemokines, proteins, proteins car-
ried by liposomes, and combinations thereof. 
21. The method according to claim 18 wherein: 
said layer containing said bioactive species is further 
coated with sacrificial layers that decompose at a desired 
rate for controlling a time at which said bioactive species 
will be released. 
22. The method according to claim 21 wherein: 
said bioactive species is in a top layer of said scaffold. 
23. The method according to claim 21 wherein: 
said layer containing said bioactive species is further 
coated with sacrificial layers that allow a release of said 
bioactive species when said bioactive species is exposed 
to external signals selected from a group consisting of 
mechanical forces, electric fields, magnetic fields, and 
electromagnetic radiation. 
24. The method according to claim 17 further comprising: 
repeating said immersing steps a predetermined number of 
times. 
25. The method according to claim 17 further comprising: 
at least one repetition of said step ofimmersing said porous 
colloidal crystal structure in a solution or dispersion of 
PDDA wherein said solution or dispersion of PDDA is 
replaced with a solution or dispersion of a third sub-
stance, said third substance having an affinity similar to 
PDDA. 
26. The method according to claim 17 wherein: 
at least one repetition of said step ofimmersing said porous 
colloidal crystal structure in a solution or dispersion of a 
second substance wherein said second solution or dis-
persion is replaced with a solution or dispersion of a 
third substance, said third substance having an affinity 
similar to PDDA. 
27. The method according to claim 17 wherein: 
said dispersion or solution of at least one of said PDDA and 
second substance is a solution or dispersion comprising 
matrix decomposition factors. 
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28. The method according to claim 1 further comprising: 
including layers in the coating that lose their structural 
integrity when exposed to treatments selected from a 
group consisting of chemicals, bioactive species, 
mechanical forces, electric fields, magnetic fields, and 5 
electromagnetic radiation. 
29. The method according to claim 1 further comprising 
the steps of: 
rinsing said porous colloidal crystal structure with water; 
10 
coating said porous colloidal crystal structure in PAA 
aqueous solution to form a thin film on said porous 
colloidal crystal structure; 
rinsing said porous colloidal crystal structure with water; 
12 
coating said porous colloidal crystal structure in an aque-
ous solution of collagen IIII to form a thin film on said 
porous colloidal crystal structure; 
rinsing said porous colloidal crystal structure with water; 
coating said porous colloidal crystal structure in PAA 
aqueous solution to form a thin film on said porous 
colloidal crystal structure; 
rinsing said porous colloidal crystal structure with water; 
coating said porous colloidal crystal structure in an aque-
ous solution of collagen IIII to form a thin film on said 
porous colloidal crystal structure; 
rinsing said porous colloidal crystal structure with water. 
* * * * * 
